İnCi Azmamedova

İnCi Azmamedova

Auto-generated profile, based on publicly available information

İnCi Azmamedova

Department of Physiology, Faculty of Medicine, Sakarya University, Sakarya, Türkiye

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SDSongul DOGANAY
Songul DOGANAY
AYAssoc. Prof. Sevinc Yanar
Assoc. Prof. Sevinc Yanar
IBİsMail Bolat
İsMail Bolat
IAInji Azmammadova
Inji Azmammadova
MAMerve Gulsen Bal Albayrak
Merve Gulsen Bal Albayrak
FNFatima Betul Nogay
Fatima Betul Nogay
Obesity is a growing global health concern that leads to metabolic imbalances and progressive cardiac remodelling. This study investigated whether semaglutide (SMG) can counteract the disruption to the gut-heart-metabolic axis and associated myocardial injury caused by obesity. Twenty-one male Wistar rats were assigned to control, obese (OB), and obese+semaglutide (OB + SMG) groups. The control group was fed a normal diet, while the obese groups were given a cafeteria diet for 16 weeks. In addition, the OB + SMG group received 150 mcg/kg of SMG subcutaneously once a week for the last four weeks. The following were measured alongside HOMA indices: Lipid profile, cardiac enzymes, leptin, insulin, TMAO and LPS levels. Myocardial and intestinal samples were assessed biochemically and histopathological for the levels of MMP-2/MMP-9, TIMP-1, TGF-β, IL-1β, HO-1, occludin, ZO-1 and claudin. Obesity markedly increased body weight, fasting glucose, leptin, insulin resistance, the atherogenic index and cardiac risk, while also increasing LPS, TMAO, TGF-β, IL-1β, MMP-2/MMP-9 activity and decreasing TIMP-1. Semaglutide significantly reversed these abnormalities, improving metabolic indices, restoring the balance between MMPs and TIMPs, and reducing inflammatory mediators. Histological analysis revealed reduced cardiomyocyte degeneration and enhanced intestinal epithelial architecture in the OB + SMG group. Semaglutide notably enhanced the expression of occludin, claudin, and ZO-1, supporting strengthened intestinal barrier integrity, and restored HO-1 expression, indicating improved antioxidant defenses. These findings suggest that semaglutide provides cardioprotection in obesity by restoring gut barrier function, reducing inflammation and normalizing extracellular matrix turnover. By stabilizing the gut-heart-metabolic axis and mitigating structural myocardial injury, semaglutide may interrupt the progression from metabolic dysfunction to cardiomyopathy. This highlights its therapeutic potential in the treatment of obesity-related cardiovascular disease, extending beyond glycemic control.

1 January 2023 in İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi
Verified
Journal Article
Open access
PDF file
IAİnci Azmamedova
İnci Azmamedova
NBNurten Bahtiyar
Nurten Bahtiyar
NCN/A Cinemre
N/A Cinemre
BABirsen Aydemir
Birsen Aydemir
17 Kasım 2019’da Çin’in Wuhan kentinde ortaya çıkan COVID-19 hastalığı, 11 Mart 2020 tarihinde Dünya Sağlık Örgütü (DSÖ) tarafından küresel salgın olarak ilan edilmiştir. Ağır hastalık tablosuna ve dünya genelinde çok sayıda ölüme neden olan bu virüs, Şiddetli Akut Solunum Sendromu-Koronavirus-2 (SARS-CoV-2) olarak adlandırılmıştır. Hastalığa tüm yaş grupları hassas olmakla beraber yaşlı bireyler ile kardiyovasküler hastalık, diyabet, kronik solunum yolu hastalığı veya kanser gibi altta yatan hastalıkları olanlarda ciddi hastalık gelişme olasılığının daha yüksek olduğu gözlenmiştir. SARS-CoV-2 virüsü yüzeyindeki proteinlerden biri olan spike (S) proteini ile alt solunum yolu epitel hücrelerinde bulunan anjiyotensin dönüştürücü enzim- 2 (ACE2) reseptörlerine bağlanarak kendi genomunu hücre sitoplazmasına bırakır ve böylece yeni virüs partiküllerinin sentezini gerçekleştirir. Yapılan çalışmalarda, COVID-19 hastalığında çeşitli hematolojik ve hemoreolojik parametrelerin değiştiği belirtilmiştir. Bu hastalıkta sıklıkla gözlenen bazı hematolojik parametreler lenfopeni, nötrofili ve trombositopenidir. Enflamasyondaki artışa bağlı olarak, trombosit aktivasyonu, endotel disfonksiyonu ve staz nedeniyle hastalarda tromboz oluşumu saptanmıştır. COVID-19 koagülopatisi ile ilgili çalışmalarda, yüksek D-dimer düzeylerinin olduğu görülmüştür. Aynı zamanda artmış fibrinojenin COVID-19 hastalarında eritrosit hiperagregasyonuna neden olduğu ve bunun da kan pıhtılaşmasının gelişmesi ile ilişkili olduğu tespit edilmiştir. Eritrositlerde deformabilite yeteneğinin azalması eritrosit rijiditesinde artış ile sonuçlanmaktadır. COVID-19 hastalığında koagülasyon/fibrinolitik sistemindeki bozulmanın sonucunda, D-dimer, kan viskozitesi, eritrosit agregasyonu ve deformabilitesi gibi hemoreolojik parametrelerin artışı hastalık prognozu ile ilişkili olduğu ileri sürülmüştür. Derlemenin amacı, COVID-19’un etiyopatogenezinde hemoreolojik parametrelerin rollerini değerlendirmektir.

30 December 2024 in İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi
Verified
Journal Article
Open access
PDF file
NBNurten Bahtiyar
Nurten Bahtiyar
BABirsen Aydemir
Birsen Aydemir
BHBurcu Hacıoğlu
Burcu Hacıoğlu
LALeyla Sevinç Afşar
Leyla Sevinç Afşar
GSGamze Savaş
Gamze Savaş
NCN/A Cinemre
N/A Cinemre
Aim: The aim of the present study was to investigate the levels of intraerythrocyte fluid volume, erythrocyte indices, and biochemical parameters and to evaluate the relationship between intraerythrocyte fluid volume and these parameters in patients with Diabetes Mellitus (DM) and healthy controls. Method: The study included 42 patients with DM and 40 healthy controls. Biochemical parameters were measured using an automated analyzer. Complete blood counts were performed using an automated hematology analyzer, and intraerythrocyte fluid volumes were measured using the microcentrifugation method. Results: Intraerythrocyte fluid volume, glycated hemoglobin (HbA1c), and glucose levels were higher in the patient group than in the control group, whereas mean corpuscular volume (MCV), potassium (K), and sodium (Na) values were lower in the patient group than in the control group. On the other hand, a negative correlation was found between intraerythrocyte fluid volume and mean corpuscular hemoglobin concentration (MCHC), magnesium (Mg), and K values in the patient group. Conclusion: Studies findings indicated that intraerythrocyte fluid volume may be an effective hemodynamic parameter in the etiopathogenesis of DM. In line with these data, it can be suggested that intraerythrocyte fluid volume is an important factor that should be considered in monitoring the progression of the disease.